CLINICAL_TRIALS
trial_result
· 2026-03-11
Clinical Trial Update: Oxytocin to Treat PTSD [Phase 2]
Summary
The VA-sponsored Phase 2 clinical trial evaluating oxytocin for post-traumatic stress disorder has completed, and the results were posted on 2026-03-11.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: VA Office of Research and Development | Conditions: PTSD | Phase 2 | Status: COMPLETED | Results posted: 2026-03-11